![Max M. Søgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max M. Søgaard
Technik-/Wissenschafts-/F&E-Leiter bei
EXPRES2ION BIOTECH HOLDING AB
Profil
Max M.
Søgaard currently works at Expres2ion Biotech Holding AB, as Chief Scientific Officer from 2025.
Dr. Søgaard received his graduate degree from the University of Aarhus and doctorate degree from University College London.
Aktive Positionen von Max M. Søgaard
| Unternehmen | Position | Beginn |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ausbildung von Max M. Søgaard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
